Last Close
Feb 05  •  04:00PM ET
34.21
Dollar change
-1.23
Percentage change
-3.46
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y37.07% Total Holdings39 Perf Week-5.10%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM89.26M Perf Month-6.00%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter7.59%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High39.60 -13.62% Perf Half Y39.03%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 82.14% Perf YTD-6.58%
Active/Passive Quant Type Tagsmedical Flows% 1M-0.82% Volatility1.71% 1.66% Perf Year39.86%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M6.80% ATR (14)0.78 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD-0.75% RSI (14)34.22 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.39 Perf 10Y-
Expense0.54% Growth/Value SMA20-5.16% Flows% 3Y Rel Volume0.33 Prev Close35.43
Inverse/Leveraged Market Cap SMA50-7.89% Flows% 5Y Avg Volume6.55K Price34.21
IPOOct 31, 2024 Option/ShortNo / Yes SMA20017.08% Trades Volume2,192 Change-3.46%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.